BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 25436993)

  • 1. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
    Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
    JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid.
    Liba Z; Kayserova J; Elisak M; Marusic P; Nohejlova H; Hanzalova J; Komarek V; Sediva A
    J Neuroinflammation; 2016 Mar; 13(1):55. PubMed ID: 26941012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.
    Kothur K; Wienholt L; Mohammad SS; Tantsis EM; Pillai S; Britton PN; Jones CA; Angiti RR; Barnes EH; Schlub T; Bandodkar S; Brilot F; Dale RC
    PLoS One; 2016; 11(8):e0161656. PubMed ID: 27575749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
    Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
    Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
    Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
    J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation.
    Li Y; Yang K; Zhang F; Wang J; Shen H; Liu M; Guo J; Wang J
    Front Immunol; 2022; 13():971659. PubMed ID: 36389787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
    Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J
    J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.
    Kothur K; Gill D; Wong M; Mohammad SS; Bandodkar S; Arbunckle S; Wienholt L; Dale RC
    Dev Med Child Neurol; 2017 Aug; 59(8):806-814. PubMed ID: 28439892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
    Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F
    J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL13 chemokine in pediatric and adult neuroborreliosis.
    Wutte N; Berghold A; Löffler S; Zenz W; Daghofer E; Krainberger I; Kleinert G; Aberer E
    Acta Neurol Scand; 2011 Nov; 124(5):321-8. PubMed ID: 21320077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
    Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
    Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
    Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
    Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-NMDAR encephalitis may develop concurrently with anti-MOG antibody-associated bilateral medial frontal cerebral cortical encephalitis and relapse with elevated CSF IL-6 and CXCL13.
    Fujimori J; Takahashi T; Kaneko K; Atobe Y; Nakashima I
    Mult Scler Relat Disord; 2021 Jan; 47():102611. PubMed ID: 33160141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients.
    Wagner JN; Weis S; Kubasta C; Panholzer J; von Oertzen TJ
    J Neurol; 2018 Jan; 265(1):74-81. PubMed ID: 29134272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.
    Kępa L; Oczko-Grzesik B; Sobala-Szczygieł B; Boroń-Kaczmarska A
    Przegl Epidemiol; 2015; 69(4):705-10, 851-5. PubMed ID: 27139348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Li Q; Chen J; Yin M; Zhao J; Lu F; Wang Z; Yu X; Wang S; Zheng D; Wang H
    Front Immunol; 2021; 12():680424. PubMed ID: 34220828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine CXCL13 in acute neuroborreliosis.
    Senel M; Rupprecht TA; Tumani H; Pfister HW; Ludolph AC; Brettschneider J
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):929-33. PubMed ID: 19965843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
    Malter MP; Elger CE; Surges R
    Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
    Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
    Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.